🔎 Trials Near Me

Home › Frailty › NCT06404970

A Partnered Evaluation to Improve the Identification and Management of Functional Impairment and Frailty Among Older Veterans in Primary Care Settings

Recruiting

A Partnered Evaluation to Improve Identification and Management of Functional Impairment and Frailty for Older Veterans in VA Primary Care

Who can join

Ages 60 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Veteran
* \>60 years old
* Seen in Veterans Health Administration primary care after implementation begins

Exclusion Criteria:

* Non-Veteran
* \<60 years old
* Not seen in Veterans Health Administration primary care

About the study

Maintaining functional status, or the ability to perform daily activities, is central to older adults' quality of life, health, and ability to remain independent. Identifying functional impairments is essential for clinicians to provide optimal care to older adults, and on a population level, understanding function can help anticipate service needs. Yet uptake of standardized measurement of functional status into patient care has been slow and inconsistent due to the burden posed by current tools. The purpose of the proposed QUERI Partnered Evaluation Initiative is to implement and evaluate a patient-centered, low-burden intervention to improve measurement of functional status in VA primary care settings nationally. The investigators hypothesize that implementing this intervention will increase identification and improve management of functional impairment among older Veterans while providing key data to inform VHA strategic planning related to long-term services and supports.

What is being tested

Sponsor: VA Office of Research and Development · Participants: 10,000 · Started: Mar 3, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06404970

Locations in the U.S.

PennsylvaniaCorporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia

Conditions

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.